MUFG Securities Americas’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.42M Buy
56,350
+1,506
+3% +$87.8K 0.22% 82
2025
Q4
$2.96M Sell
54,844
-44
-0.1% -$2.12K 0.18% 104
2025
Q3
$2.48M Buy
54,888
+9,785
+22% +$457K 0.16% 118
2025
Q2
$2.09M Buy
45,103
+9,182
+26% +$451K 0.18% 111
2025
Q1
$2.19M Buy
35,921
+5,982
+20% +$349K 0.25% 83
2024
Q4
$1.69M Buy
+29,939
New +$1.67M 0.21% 90

Other funds holding BMY

MUFG Securities Americas's BMY Position: Q1 2026 in Review

MUFG Securities Americas increased its Bristol-Myers Squibb (BMY) stake by 2.7% in Q1 2026, buying an estimated $87.8K and bringing the position to 56,350 shares worth $3.42M. The position accounts for 0.22% of the portfolio, ranked #82.

MUFG Securities Americas first reported a position in BMY in Q4 2024 and has held it in 6 quarters since. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • MUFG Securities Americas held 56,350 shares of Bristol-Myers Squibb worth $3.42M as of Q1 2026.
  • MUFG Securities Americas bought 1,506 Bristol-Myers Squibb shares in Q1 2026, an estimated $87.8K.
  • Bristol-Myers Squibb made up 0.22% of MUFG Securities Americas's portfolio in Q1 2026, its #82 holding.
  • MUFG Securities Americas first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 6 quarters since.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on MUFG Securities Americas's 13F filing for Q1 2026, filed 11 May 2026.